FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/07/071416 [Registered on: 26/07/2024] Trial Registered Prospectively
Last Modified On: 25/07/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Physiotherapy (Not Including YOGA) 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Reach Out and Read Programme for Neurodevelopment in High risk babies of 1 year of age 
Scientific Title of Study   Effectiveness of Reach Out and Read Program on Neurodevelopment at 1 year in High risk infants A Randomized Controlled trial  
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Ketaki Karnik 
Designation  Post graduate student 
Affiliation  KLE Institute of Physiotherapy Belgaum 
Address  Advanced Physiotherapy center, department of pediatric physiotherapy room no 39, sagar floor, Belgaum Karnataka

Belgaum
KARNATAKA
590010
India 
Phone  8450938733  
Fax    
Email  ketaki2209@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Vinuta Deshpande 
Designation  Assistant Professor 
Affiliation  KLE Institute of Physiotherapy Belgaum 
Address  Advanced Physiotherapy center, department of pediatric physiotherapy room no 39, sagar floor, Belgaum Karnataka

Belgaum
KARNATAKA
590010
India 
Phone  8754466612  
Fax    
Email  vinuta.gangavatikar@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Ketaki Karnik 
Designation  Post graduate student 
Affiliation  KLE Institute of Physiotherapy Belgaum 
Address  Advanced Physiotherapy center, department of pediatric physiotherapy room no 39, sagar floor, Belgaum Karnataka

Belgaum
KARNATAKA
590010
India 
Phone  8450938733  
Fax    
Email  ketaki2209@gmail.com  
 
Source of Monetary or Material Support  
KLE Dr Prabhakar Kore Hospital and Research center, Nehru Nagar, Belgaum 590010, Karnataka,India  
 
Primary Sponsor  
Name  Ketaki Karnik 
Address  Advanced Physiotherapy center, department of pediatric physiotherapy room no 39, sagar floor, Belgaum KARNATAKA 590010  
Type of Sponsor  Other [self sponsored] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Ketaki Karnik  KAHER institute of physiotherapy  Advanced Physiotherapy center, department of pediatric physiotherapy room no 39, sagar floor, Belgaum Karnataka
Belgaum
KARNATAKA 
8450938733

ketaki2209@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Research and ethical committee KAHER Institute of Physiotherapy  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Healthy Human Volunteers  infants coming to high risk 
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Reach Out and Read Program  parents of infants visiting high risk clinic will be given age-appropriate books in their vernacular language and will be taught how to perform the task at their visit to high risk clinic at 6 months of age and will be followed at 8 and 10 months of age where new age appropriate books will be given 
Comparator Agent  Standard education  parents will be explained importance of neurodevelopment and will be guided on how to achieve it the intervention will continue for 6 months and at the third visit post assessment evaluation will be taken 
 
Inclusion Criteria  
Age From  6.00 Month(s)
Age To  12.00 Month(s)
Gender  Both 
Details  1. Male and female Infants who visit the High Risk clinic, at tertiary care hospital, Belagavi
2. Infants whose mothers are able to read and comprehend in vernacular language
3. Parents who are willing to participate
 
 
ExclusionCriteria 
Details  1. Infants who are critically ill.
2. Infants who are referred for any surgeries in next 6 months.
3. Infant with genetic disorders, congenital anomalies, metabolic diseases
4. Infants with known neuromotor disabilities
 
 
Method of Generating Random Sequence    
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Participant Blinded 
Primary Outcome  
Outcome  TimePoints 
Bayley Scales of Infant and Toddler Development - IV   T0 at baseline at 6 months of age
T1 at 8 months of age
T2 at 10 months of age
T3 post assessment at 12 months of age 
 
Secondary Outcome  
Outcome  TimePoints 
NIL  NIL 
 
Target Sample Size   Total Sample Size="34"
Sample Size from India="34" 
Final Enrollment numbers achieved (Total)= "0"
Final Enrollment numbers achieved (India)="34" 
Phase of Trial   N/A 
Date of First Enrollment (India)   12/08/2024 
Date of Study Completion (India) 25/03/2025 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Date Missing 
Estimated Duration of Trial   Years="0"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Completed 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   The study, titled "Effectiveness of Reach Out and Read program on Neurodevelopment at 1 year in High-risk Infants: A Randomized Controlled Trial," aims to evaluate the impact of the Reach Out and Read (ROR) program on the neurodevelopment of high-risk infants at one year of age. The ROR program is an early literacy intervention designed to promote early language and cognitive development through parent-child reading activities. This study aims to determine the effectiveness of the Reach Out and Read programme on Neurodevelopment at 1 year in high risk infants. The hypothesis is that high-risk infants who participate in the ROR program will demonstrate better neurodevelopmental outcomes at one year of age, as measured by the Bayley Scales of Infant and Toddler Development-IV (BSID-4) or the Oxford Neurodevelopment Assessment (OX-NDA), compared to those who do not receive the intervention. 
Close